These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17631220)

  • 1. "Crying fire in a theater" or a "confirmatory sighting?".
    Ellis SG
    J Am Coll Cardiol; 2007 Jul; 50(3):268-9. PubMed ID: 17631220
    [No Abstract]   [Full Text] [Related]  

  • 2. Repetita iuvant.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):468-9. PubMed ID: 18819144
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Van den Branden F; Van Langenhove G;
    J Am Coll Cardiol; 2007 Jul; 50(3):261-7. PubMed ID: 17631219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
    Belardi J
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stent in saphenous vein graft lesions.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
    [No Abstract]   [Full Text] [Related]  

  • 9. Results and follow-up after implantation of four or more sirolimus-eluting stents in the same patient.
    Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Vitrella G; Ferraro M; Colombo A
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):436-9; discussion 440-1. PubMed ID: 15789401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed occurrence of restenosis in drug eluting stents: an evidence of delayed healing.
    Sapra R; Kaul U; Gupta RK; Kachru R; Ghose T; Sharma S; Parida AK; Samal MP; Singh B
    J Assoc Physicians India; 2005 May; 53():483-5. PubMed ID: 16124361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical and angiographic outcome of sirolimus-eluting stent implantation versus cutting balloon angioplasty for coronary in-stent restenosis.
    Airoldi F; Rogacka R; Briguori C; Chieffo A; Carlino M; Montorfano M; Mikhail G; Iakovou I; Michev I; Vitrella G; Albiero R; Colombo A
    Am J Cardiol; 2004 Nov; 94(10):1297-300. PubMed ID: 15541251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
    Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
    Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
    JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
    Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE
    Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).
    Indolfi C; Pavia M; Angelillo IF
    Am J Cardiol; 2005 May; 95(10):1146-52. PubMed ID: 15877984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?
    Jensen J; Lagerqvist B; Aasa M; Särev T; Nilsson T; Tornvall P
    J Intern Med; 2006 Aug; 260(2):118-24. PubMed ID: 16882275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sirolimus-eluting stent for in-stent restenosis treatment: single center results in an unselected study population].
    Bellandi F; Toso A; Maioli M; Leoncini M; Dabizzi RP
    Ital Heart J Suppl; 2005 Sep; 6(9):599-603. PubMed ID: 16281719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.